5 Amino 1 MQ Protocol
Dosing & Research
Last Updated: April 22, 2026
NNMT inhibition, Adiposity and body-composition studies, Insulin-sensitivity models, NAD+ salvage/metabolic research
Half-Life
Not Well Characterized In Humans
Administration
Subcutaneous
Frequency
Once Or Twice Daily
How It Works
- NNMT inhibition
- Adiposity and body-composition studies
- Insulin-sensitivity models
- NAD+ salvage/metabolic research
Dosing Structure
Dose
250mcg-5mg/day (2.5mg twice daily most common)
Frequency
Once Or Twice Daily
Notes
SubQ only: Starting dose 250mcg, standard range 2.5mg twice daily or 5mg once daily (max 5mg/day). Inject: Abdomen, thigh (rotate sites). Morning injection preferred. Reconstitute with bacteriostatic water. Break: 4-8 weeks off between cycles. Note: Oral protocols cited in some sources lack peer-reviewed research backing and have been removed from this reference.
Example Protocols
Dose: 250mcg-5mg/day (2.5mg twice daily most common)
Frequency: Once Or Twice Daily
Duration: 8-12 weeks on, 4-8 weeks off
Off Period: Not listed
Protocol Notes
•
SubQ only: Starting dose 250mcg, standard range 2.5mg twice daily or 5mg once daily (max 5mg/day).
•
Inject: Abdomen, thigh (rotate sites).
•
Morning injection preferred.
•
Reconstitute with bacteriostatic water.
•
Break: 4-8 weeks off between cycles.
•
Note: Oral protocols cited in some sources lack peer-reviewed research backing and have been removed from this reference.
Research & Studies
Loading citations…
Research Feedback
0 approved
For research discussion only. Community feedback is moderated and shown here as aggregated insights after approval.
Be the first to submit research feedback for this peptide.
Approved submissions will appear here as aggregated insights.